Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
(Adnkronos) – TÜBINGEN, Germany, Jan. 9, 2024 /PRNewswire/ — Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as
